The "tipping point" for breast cancer mortality decline has resulted from size reductions due to mammographic screening

Annals of Surgical Oncology

Volumn 18, Issue 4, 2011, Pages 903-906

  Cady, Blake ^a,b   Michaelson, James S ^c   Chung, Maureen A ^d  

^a CAMBRIDGE HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; BREAST CANCER; CANCER GRADING; CANCER MORTALITY; EARLY DIAGNOSIS; EDUCATIONAL STATUS; HUMAN; LYMPH NODE METASTASIS; MAMMOGRAPHY; PROGNOSIS; REVIEW; SENTINEL LYMPH NODE BIOPSY; SOCIAL STATUS; TUMOR VOLUME;

BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MAMMOGRAPHY; SURVIVAL RATE;

EID: 79955809897     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1557-y     Document Type: Review

References (17)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer Statistics, 2010. CA: A Cancer J Clin. 2010. doi:10.3322/caac.20073.
2. Torio CM, Klassen AC, Curriero FC, Caballero B, Helzlsouer K. The modifying effect of social class on the relationship between body mass index and breast cancer incidence. Am J Public Health. 2010;100:146-51
3. Cady B, Stone MD, Schuler JG, Thakur R, Wanner MA, Lavin PT. The new era in breast cancer. Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening. Arch Surg. 1996;131:301-8. (Pubitemid 26078817)
4. Coburn NG, Chung MA, Fulton J, Cady B. Decreased breast cancer tumor size, stage, and mortality in Rhode Island: an example of a well-screened population. Cancer Control. 2004;11: 222-30. (Pubitemid 38970623)
5. Coburn NG, Fulton JP, Cady B, Law C, Chung MA. Continuously improving size, lymph node metastatic rate, and mortality of invasive breast cancer in Rhode Island women, a well screened population. Cancer. Submitted.
6. Gur AS, Unal B, Johnson R, et al. Predictive probability of four different breast cancer nomograms for nonsentinel axillary lymph node metastasis in positive sentinel node biopsy. J Am Coll Surg. 2009;208:229-35.
7. Giuliano AEML, Beitsch P, Whitworth PW, et al. Local and regional control in breast cancer after sentinel node biopsy without axillary node dissection: results from a randomized trial. Ann Surg. 2010;252:426-32.
8. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 1985;312:1604-8. (Pubitemid 15062653)
9. Hellman S. Karnofsky Memorial Lecture. Natural history of small breast cancers. J Clin Oncol. 1994;12:2229-34.
10. Gaudette LA, Altmayer CA, Nobrega KM, Lee J. Trends in mammography utilization, 1981 to 1994. Health Rep. 1996;8: 17-27.
11. Hunt KA, Rosen EL, Sickles EA. Outcome analysis for women undergoing annual versus biennial screening mammography: a review of 24,211 examinations. AJR Am J Roentgenol. 1999;173: 285-9. (Pubitemid 29347342)
12. Smart CR, Byrne C, Smith RA, et al. Twenty-year follow-up of the breast cancers diagnosed during the Breast Cancer Detection Demonstration Project. CA Cancer J Clin. 1997;47:134-49. (Pubitemid 27226280)
13. Byers T, Mouchawar J, Marks J, et al. The American Cancer Society challenge goals. How far can cancer rates decline in the U.S. by the year 2015? Cancer. 1999;86:715-27.
14. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2009;151:727-37.
15. Michaelson JS, Satija S, Kopans D, et al. Gauging the impact of breast carcinoma screening in terms of tumor size and death rate. Cancer. 2003;98:2114-24. (Pubitemid 37392414)
16. Spencer DB, Potter JE, Chung MA, Fulton J, Hebert W, Cady B. Mammographic screening and disease presentation of breast cancer patients who die of disease. Breast J. 2004;10:298-303. (Pubitemid 38924465)
17. Cady B, Webb M, Michaelson JS, Kopans D, Smith BL. Women who die of breast cancer are predominantly those not participating in regular mammographic screening. Presented at American Society of Clinical Oncology Breast Cancer Meeting, September. 2009, San Francisco, CA.